Clinical Trials Logo

Clinical Trial Summary

The proposed study is a single-center, phase II, randomized, double-blind, parallel-group, active-placebo-controlled trial of intravenous low-dose ketamine in patients with MS fatigue.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05378100
Study type Interventional
Source Johns Hopkins University
Contact Lauren Vega, BSN
Phone 410-614-1522
Email ldimarc2@jhmi.edu
Status Recruiting
Phase Phase 2
Start date January 1, 2023
Completion date March 1, 2026